FDA Plans AI Pilot for Faster Drug Trials
The US Food and Drug Administration plans to pilot artificial intelligence this summer to pull clinical trial data directly from electronic health records and send the data in real time to drugmakers and regulators. The effort is intended to give the agency and companies more visibility into trials while they are underway and cut the time needed to test new medicines.
The proposal is aimed at speeding trials, getting drugs to patients faster and supporting the US biotech sector. It could shave months, if not years, off drug development times.
From the sources (4 posts)
@firstsquawkTHE FDA LEVERAGES ARTIFICIAL INTELLIGENCE TO ACCELERATE CLINICAL TRIALS — WSJ.
@wallstengineThe FDA plans to pilot AI this summer to pull clinical trial data directly from electronic health records and send it in real time to drugmakers and regulators. The goal is to speed up trials, get drugs to patients faster, and boost U.S. bi
@businessThe US FDA plans to cut the time it takes drug companies to test new medicines by getting more visibility into clinical trials as they’re underway
@stockmktnewzThe US Food and Drug Administration plans to cut the time it takes drug companies to test new medicines by getting more visibility into clinical trials as they’re underway The proposal could shave off “months, if not years” off of drug dev